AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

4-day Plaque Accumulation Model Evaluating Compound Containing Gum

RecruitingNAAges 18 Years - 65 YearsAllLactea Therapeutics, LLC
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This will be a single-blind, single-center, 3-way crossover, randomized controlled clinical trial with 3 treatment periods utilizing 32 subjects. (Fig 1, in protocol) Each treatment period will be 4 days (96 hours +/-3 hours) in accordance with the plaque accumulation model using one of the following treatment groups: an active compound MIIP-E2 gum (experimental regimen), an inactive compound gum (negative control regimen), and a no-gum (control regimen).

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adult subjects between 18 and 65 years old * Willing to read and sign the IRB-approved informed consent. * Healthy, as determined by pertinent medical history at the study dentist's discretion. * A minimum of 20 natural teeth (excluding third molars) with at least two scorable surfaces per tooth (teeth with full crowns, large/extensive restorations on the interproximal areas, and orthodontic bands will not be included in the tooth count) * PLI of 2 or greater (Based on the Turesky modification of the Quigley and Hein Plaque Index) calculation based on a whole mouth plaque score. * Willing to comply with the study procedures. Exclusion Criteria: * Presence of any acute or chronic condition, organ system disease, or medication that, in the principal investigator's opinion, could compromise the subjects' ability to participate in the study. * Gross oral pathologies, including caries, calculus, or soft tissue conditions that show evidence of chronic neglect. * Evidence of acute periodontal conditions or periodontitis with pockets greater than 5 mm on more than one site * Use of antibiotics 30 days prior to or during the study * Requiring the need for antibiotic premedication prior to dental procedures * Sensitivity to bovine products (lactoferrin) or any of the listed inactive ingredients * Orthodontic appliances or any removable, except lingual bar retainers * Self-reported pregnant, wanting to get pregnant, or breast-feeding female, * Self-reported allergy to disclosing solution ingredients (red dye #28) * Acute Temporomandibular Disorders (TMD) * Subject who has participated in other studies (including non-medicinal studies) involving product(s) within 30 days before study screening. * Subject who has previously been randomized in this study * An employee of the study site directly involved with the study
๐Ÿ’Š

What it tests

  • MIIP-E2 containing gum
  • placebo gum without MIIP-E2
๐Ÿ“

Where

1 site
Oral Health Research Institute
Indianapolis, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy